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1. Introduction
Spatial fractionation is an approach in radiation therapy (RT) that uses highly inhomogeneous radiation fields 
which are periodically segmented into regions of high dose and regions of low dose separated by step-like 
gradients. The concentration of ionising radiation into confined volume sections, while not directly irradiating 
the remaining tissue, presents benefits for the recovery of normal tissue from radiation damage. This has been 
known since the beginning of the 20th century for grid therapy, where a coarse spatial fractionation with beam 
sizes in the order of millimetres to centimetres was used to spare the skin from high entrance doses (Laissue et al 
2012) in orthovoltage RT.
Microbeam radiation therapy (MRT) (Bräuer-Krisch et al 2010) takes spatial fractionation to a much smaller 
scale, where arrays of parallel planar beams with sizes of tens to hundreds of micrometres are employed. The 
resulting dose pattern consists of dose peaks at the directly irradiated regions and dose valleys where only scat-
tered particles can generate dose.
Microbeams with peak doses of hundreds of Gray have shown to inhibit tumour growth (Laissue et al 1998, 
Bouchet et al 2010, 2016), while healthy tissue exhibits an extraordinarily fast recovery after microbeam irradia-
tion (Laissue et al 2001, Serduc et al 2006).
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Abstract
Motivation. With interlaced microbeam radiation therapy (MRT) a first kilovoltage radiotherapy 
(RT) concept combining spatially fractionated entrance beams and homogeneous dose distribution 
at the target exists. However, this technique suffers from its high sensitivity to positioning errors of 
the target relative to the radiation source.
With spiral microbeam radiation therapy (spiralMRT), this publication introduces a new 
irradiation geometry, offering similar spatial fractionation properties as interlaced MRT, while being 
less vulnerable to target positioning uncertainties.
Methods. The dose distributions achievable with spiralMRT in a simplified human head geometry 
were calculated with Monte Carlo simulations based on Geant4 and the dependence of the result on 
the microbeam pitch, total field size, and photon energy were analysed. A comparison with interlaced 
MRT and conventional megavoltage tomotherapy was carried out.
Results. SpiralMRT can deliver homogeneous dose distributions, while using spatially fractionated 
entrance beams. The valley dose of spiralMRT entrance beams is by up to 40% lower than the 
corresponding tomotherapy dose, thus indicating a better normal tissue sparing. The optimum 
photon energy is found to be around 150 keV to 200 keV.
Conclusions. SpiralMRT is a promising approach to delivering homogeneous dose distributions 
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There is evidence that normal tissue tolerance to MRT mainly depends on the valley dose and that its dose 
thresholds for normal tissue complications correlate with the thresholds for conventional RT (Dilmanian et al 
2002, Smyth et al 2016), as long as the width of the primary radiation peaks stays below a certain limit (Serduc 
et al 2014).
The disadvantage of orthovoltage x-rays used for MRT is the strong beam attenuation with depth demanding 
for a high entrance dose when treating deep-seated tumours. Amongst other techniques, interlacing microbeams 
(Dilmanian et al 2006, Serduc et al 2010) has been proposed to increase the dose to the tumour and reduce the 
dose at the beam entrance. The interlacing approach uses multiple microbeam arrays from different directions, 
where the microbeams from different arrays are aligned in parallel and neatly join with their edges.
The number of microbeam arrays, also called fields, from different directions can be increased such that the 
interlaced microbeams at the intersection completely fill up the target volume, generating a homogeneous dose 
distribution. The major advantage is a uniform high dose coverage of the target volume as in conventional radia-
tion therapy, while the surrounding normal tissue benefits from spatial fractionation.
The challenge of interlaced microbeam irradiations is the required precision in positioning when changing the 
beam direction. The alignment between patient and radiation source requires a precision in the order of 10 µm. 
Otherwise, adjacent microbeams may overlap or leave gaps in the dose pattern. To date it is uncertain if this preci-
sion can be met with the currently available technology. Taking into account that the patient is deformable and 
moving adds another source of uncertainty, even if the positioning device meets the mechanical requirements.
As an alternative to interlaced microbeams, this publication presents the concept of spiral microbeam radia-
tion therapy (spiralMRT)—a novel irradiation geometry which provides a homogeneous dose at the target and 
a spatial fractionation of the entrance beam, which can be delivered in one smooth and continuous movement 
of either the patient or the radiation source, thus avoiding the aforementioned potential errors in positioning.
2. The concept of spiral microbeam radiation therapy
The new irradiation geometry spiral microbeam radiation therapy (spiralMRT) uses a continuous irradiation 
with one single photon microbeam on a target which is performing a spiral motion, i.e. rotation and 
simultaneous translation along the rotation axis. As evident from figure 1, the microbeam cross section has its 
long extension along the tangential vector of the rotation and the short extension, which is responsible for the 
fluence modulation, parallel to the rotation axis. The centre of the microbeam is aligned with the rotation axis.
This setup results in a helical dose delivery, depositing a quasi-homogeneous dose inside a cylindrical volume 
centred on the rotation axis, where the pitch of the motion pattern is defined as the linear translation per one full 
rotation. The diameter and height of this cylinder of homogeneous dose naturally correspond to the horizontal 
extension of the primary microbeam and the range of the helical target motion during the irradiation. At the 
beam entrance, the microbeam structure is preserved by the rotation, resulting in a helical shape of the deposited 
dose.
There are several anticipated advantages of spiralMRT when compared to dose delivery with multiple static 
interlaced microbeam fields intersecting at the target:
 •  The overall beam entrance surface is increased, thus distributing the entrance dose over a larger volume and 
lowering it.
 •  The need for mechanical precision is reduced to continuous longitudinal and rotational motion, but there 
is no need for precise interlacing of several microbeam arrays. Positioning errors arising from mechanical 
backlash of the positioning device when moving source or patient up and down become irrelevant.
 •  Robustness to target motion is improved. In analogy to spiral computed tomography imaging, the 
continuous irradiation ensures that no part of the target can be missed due to organ motion between two 
irradiations from different directions.
 •  A short exposure time is usually demanded in MRT, in order to keep blurring of microbeams by organ 
motion as low as possible. This is achieved by using high dose rates around 10 kGy s−1 (Fournier et al 
2016) produced at synchrotron sources. The exposure time at the target, where the dose distribution is 
homogeneous, is defined by the dose rate and the dose prescription. In the outer regions, the time span 
during which a tissue segment is actually exposed to the beam may be substantially shorter, which reduces the 
impact of microbeam blurring caused by organ motion.
  Furthermore, the homogeneous dose at the target will rather be in the order of 10 Gy–20 Gy, while pure 
microbeam treatments currently aim for doses bigger than 100 Gy in the microbeam peak. Thus, at 
equivalent dose rate, a shorter exposure time can be achieved.
The geometry was introduced here with a static radiation source and a moving target, but naturally the reversed 
setup consisting of a gantry-mounted rotating radiation source and a static target would equally work.
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3. Method
The characteristics of a spiralMRT treatment are assessed using Monte Carlo methods for radiation transport. 
Variations of the photon energy, the microbeam pitch and the overall field size are taken into account in the 
simulations in order to identify their impact on the resulting dose distribution, which is assessed by extracting 
characteristic quality indicators. The details are explained in the sections here below.
3.1. Simulation and modelling
The achievable spiralMRT dose distributions are calculated in a simplified human head phantom, consisting 
of three different materials: skin, brain, and cortical bone according to the ICRU definition. The phantom is 
arranged in three coaxial cylinders of 175 mm height. The outer diameter is 175 mm with a 5 mm layer of skin 
and a 7 mm layer of bone, while the remaining inner part of the phantom is filled with brain material.
The calculation of dose deposition is carried out using a Monte Carlo simulation based on the Geant4 
(Agostinelli et al 2003, Allison et al 2006) toolkit. As underlying physics model the Penelope physics list is 
employed.
The radiation source is modelled as a rectangular planar source emitting parallel monochromatic photons of 
homogeneous intensity perpendicular to its surface. In the calculations the source is moving on a spiral trajec-
tory at 200 mm distance from the rotation axis around the static phantom in air. Rotation axis and cylinder axis 
of the phantom are chosen to coincide and the central axis of the incoming microbeam is perpendicular to the 
cylinder surface.
To facilitate the calculation, the reference system is chosen to have the phantom static and having the source 
rotate around it.
For modelling spiralMRT as a Monte Carlo simulation, the total irradiation time is calculated from the total 
field height and the linear component of the spiral motion in order to sample random points in time during the 
irradiation. From the random time point then the current position of the microbeam source can be calculated and 
a random position within the rectangular microbeam cross section is sampled to generate the origin of a photon.
The deposited dose is scored in a plane spanned by the cylinder axis of the phantom and an arbitrary radial 
vector of the corresponding cylinder. The scoring plane is segmented into 360× 5000 pixels (along radial vector 
× along rotation axis) with a size of 500 µm× 5 µm, which results in a total extension of the scoring plane of 
180 mm in lateral and 25 mm in vertical direction. The thickness of the scoring plane is 1 mm.
Within a range of 3 mm around the scoring plane, the tracking properties of the Monte Carlo simulation are 
adapted to the dimensions of the scoring grid. Secondary particle production cuts are reduced to 1 µm and the 
maximum step size for electrons is limited to 5 µm. Outside this fine tracking region, the simulation properties 
are coarser to improve the time-efficiency of the calculation.
The setup of the simulation geometry is shown in figure 2.
3.2. Selection of exemplary cases and parameters
A series of spiralMRT simulations was run with a fixed primary beam size of 50 µm× 20 mm and a total field 
height of the irradiated region of 20 mm. The field height is defined by the translation along the rotation axis of 
the helical motion.
A first set of spiralMRT data was acquired with three different beam energies (100 keV, 150 keV and 200 keV) 
at a pitch of 300 µm. For comparison a dose distribution of a 6-port interlaced microbeam geometry at 150 keV 
Figure 1. Illustration of the spiralMRT irradiation geometry. The target (green cylinder) performs a rotation and vertical 
translation while being continuously irradiated by a photon microbeam.
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photon energy was calculated. The interlaced microbeam irradiation consisted of six identical radiation fields, 
each composed of 67 beamlets (50 µm thick and 20 mm long) spaced by 300 µm pitch. The pitch is also known as 
centre-to-centre distance of the microbeam peaks. The beam angles were equally separated by 60◦. It was made 
sure that microbeams from adjacent fields do not directly join.
Furthermore, an ideal monochromatic 2 MeV tomotherapy plan without intensity modulation and with 
homogeneous photon intensity was calculated, in order to compare spiralMRT to conventional RT. All configu-
rations mentioned so far covered a total radiation field of 20 mm× 20 mm (horizontal extension × field height) 
at the target located in the centre of the phantom cylinder. The resulting cylindrical region of dose deposition in 
the phantom centre is also referred to as target region. The central beam axis is always perpendicular on the cylin-
der surface.
Based on the outcome of the first dataset, for 150 keV and 200 keV photon energy the pitch was increased to 
450 µm and 600 µm in a second set of spiralMRT simulations. In the first simulation 100 keV photon energy did 
not appear as promising as 150 keV and 200 keV (see sections 4.1 and 4.3) and was therefore not included in the 
following simulations. Increasing the pitch is expected to result in a lower valley dose between the microbeams, 
which is associated with benefits for normal tissue (Dilmanian et al 2002, Smyth et al 2016). The field size was 
kept at 20 mm× 20 mm.
Finally, a comparison for field sizes of 20 mm× 20 mm, 10 mm× 10 mm and 2 mm× 2 mm at 150 keV 
spiralMRT and for a 2 MeV tomotherapy plan was generated to investigate the dependence of the outcome on the 
field size. The smallest field is of particular interest for applications in neurosurgery using ionising radiation, e.g. 
treatment of drug-resistant epilepsy (Romanelli et al 2012, Studer et al 2015, Pouyatos et al 2016).
All dose distributions were normalised to one at the centre of the target region, which is located at r  =  0. To 
maintain comparability between the datasets and remove the impact of statistical noise, the dose distributions 
were divided by the average dose along the central 1.8 mm in z-direction, which correspond to the least common 
multiple of the different pitches used in this study.
The different parameter sets are summarised in table 1.
3.3. Analysis of the spatial fractionation properties
In order to evaluate the potential normal tissue sparing of orthovoltage spiralMRT, the calculated dose 
distributions are compared to megavoltage tomotherapy. As stated in section 1, the normal tissue sparing of 
spatially fractionated irradiation relies on the existence of an extended low-dose valley region. Thus, the 
spiralMRT valley dose must be lower than the tomotherapy dose to offer benefits to healthy tissue.
For all examined beam configurations, the central 1.8 mm of each dose distribution were analysed at different 
radii from the rotation axis. The volume fraction where the dose arising from spiralMRT irradiation is lower than 
the dose of the corresponding tomotherapy plan was extracted, alongside with the width of the regions where the 
peak dose is higher than the dose from tomotherapy. This is illustrated in figure 3. Furthermore, the mean dose in 
the region with a valley dose lower than the tomotherapy dose is calculated.
It should be noted that for the width of the peak a distinction between the higher entrance peaks and lower 
exit peaks must be made, as visible on figure 3. The exit peaks are due to the fact that the x-ray beam continues 
Figure 2. Transection view of the phantom geometry used for Monte Carlo simulations. The x-ray microbeam is entering from the 
right of the drawing and shown in pink. The drawing is not to scale.
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propagating behind the target region. They appear in the middle of the valley regions between two entrance 
peaks due to the 180◦ offset of the propagation direction to the entrance peaks.
4. Results
The relative statistical uncertainties (1 standard deviation of the mean) of the dose distributions presented in 
this section are below 1% within the target region for all irradiation geometries. Outside the target region, the 
statistical uncertainties are below 1% for the entrance peaks (spiralMRT and interlaced MRT), below 4% for 
exit peaks and valley regions (spiralMRT and interlaced MRT), and below 3% for tomotherapy. For a better 
readability of the data, no error bars are plotted.
4.1. Dose distributions
The simulated doses showed the anticipated spatial pattern with a homogeneously irradiated region at the centre 
of rotation and a microbeam pattern along the beam in the outer regions. As shown in figure 4, the width of the 
dose peaks decreases with increasing radius from the rotation axis, due to the increasing cross-radial velocity 
of the phantom. The exposure time to the microbeam thus decreases and the impact of the smearing linear 
component of the spiral motion is reduced. More details on this aspect are given later on in section 5. The exit 
peaks appearing between each two entrance peaks can well be identified by their decreasing intensity with 
increasing radius, due to attenuation and decreasing exposure time as the angular velocity increases.
The detailed dose pattern in the vertical centre of the irradiated region (z  =  0) is plotted in figures 5 and 6 
for different radii. As expected, at r  =  0 the dose profile is uniform for all cases. At the edge of the target region 
(r  =  10 mm) a ripple pattern is observed for spatially fractionated cases due to the slightly different penetration 
depth of the beam when impinging from different directions (see also figure 7, which depicts the dose fall-of with 
increasing penetration depth within the target region.). However, throughout almost the whole regarded region 
the dose is still higher than what would be delivered by tomotherapy without intensity modulation, which here 
only reaches  ∼90% of the dose at the centre of the target.
Outside the homogeneously irradiated region, the dose pattern transforms into clearly separated microbe-
ams. Figure 5 shows a distinctly higher valley dose for 100 keV photons, especially in the bone region around 
80 mm radius, when compared to 150 keV and 200 keV photons.
Figure 6 shows that at large radius 200 keV photons give a lower minimum value in the valley than 150 keV 
photons, but also lead to more spreading of the microbeam peak due to the higher secondary electron range. This 
can be seen by the rounded edges at the interface between peak and valley region.
For a better understanding of the evolution of the dose deposited in the centre of the peak and the valley 
region with depth, these have been plotted in figure 7 according to the definition in figure 4. They show a clear 
reduction of the entrance peak dose and the valley dose outside the target region for photon energies of 150 keV 
and 200 keV compared to 100 keV. Photoelectric absorption of orthovoltage x-rays leads to increased doses in 
bone, in particular for low photon energies.
Table 1. The different simulation configurations are grouped in 3 sets. The pitch is only relevant for spiralMRT and interlaced MRT.
Set 1—constant field size 20 mm× 20 mm—beam pitch 300 µm—variable photon energy
Irradiation geometry Photon energy
spiralMRT 100 keV, 150 keV, 200 keV
Interlaced 150 keV
Tomotherapy 2 MeV
Set 2—constant field size 20 mm× 20 mm—variable pitch—variable photon energy
Irradiation geometry Pitch Photon energy
spiralMRT 450 µm 150 keV, 200 keV
600 µm 150 keV, 200 keV
Tomotherapy  2 MeV
Set 3—constant pitch 600 µm—constant photon energy—variable field size
Irradiation geometry Photon energy Field size
spiralMRT 150 keV (2 mm)2, (10 mm)2, (20 mm)2
Tomotherapy 2 MeV (2 mm)2, (10 mm)2, (20 mm)2
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4.2. Dependence on the field size
Microbeam profiles at different radii are shown for different fields sizes in figure 8. All three presented cases 
exhibit a homogeneous dose close to the rotation axis. The 10 mm field provides a dose at the target border 
(r  =  5 mm) which is higher than the dose from tomotherapy throughout the regarded volume.
As expected, assuming identical target dose, the peak and valley dose outside the target region are reduced 
when moving to smaller fields. However, in all cases the valley dose stays below the tomotherapy dose.
The 2 mm spiralMRT field in the right column exhibits a steep gradient and a box-like dose distribution. The 
tomotherapy dose distribution cannot provide such steep gradients and the dose distribution is less confined. 
This spiralMRT dose distribution is expected to be an advantage for the treatment of neurological indications 
like epilepsy, where small localised tissue portions are to be targeted.
4.3. Spatial fractionation properties
The characteristic values (mean dose below tomotherapy dose, volume fraction below tomotherapy dose, and 
width of the microbeams exceeding the tomotherapy dose) to compare spiralMRT and tomotherapy defined 
in section 3.3 are plotted in figure 9 for radii  >10 mm. The data is separated into three columns which represent 
the three regarded pitches of 300 µm, 450 µm and 600 µm for spiralMRT and interlaced MRT in this study. The 
first two rows show the mean dose in the region that stays below the dose of a homogeneous 2 MeV tomotherapy 
irradiation, which is also plotted for comparison. The largest part of this region constitutes the valley region, but 
it includes also the lower part of the penumbra. The lower the dose is in this region is, the higher are the expected 
benefits for healthy tissue, as some authors (Dilmanian et al (2002) and Smyth et al (2016)) argue that MRT 
normal tissue tolerance depends on the valley dose and has similar threshold doses as conventional RT.
Subplots (a)–(c) show the dose normalised by the dose at the target point, while (d)–(f) show the same data 
normalised by the tomotherapy dose at the corresponding radius from the rotation axis. Subplot (d) shows data 
for 300 µm pitch and illustrates the aforementioned increase in valley dose for 100 keV photons at shallow depth. 
Figure 3. Definition of the characteristic values for the comparison of spiralMRT and tomotherapy. The regions indicated as volume 
fraction below/above TT are illustrating the volume where the spiralMRT dose is below/above the tomotherapy dose.
Figure 4. Dose distribution of the 200 keV/450 µm pitch dataset along the plane bisecting the phantom cylinder along its central 
axis. Note the different scales in the two dimensions and the logarithmic color bar. The indicated peak and valley profiles are plotted 
in figure 7 for different energies.
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The 6-port interlaced geometry yields an extremely low dose close to the target, but then the normalised dose 
rises quickly towards the beam entrance. At r  >  60 mm, peak and valley dose from interlaced MRT both stay 
above the reference dose from tomotherapy, therefore no data points for interlaced MRT are plotted above this 
radius in subplot (d).
Subplots (e) and (f) indicate that the valley dose can be lowered when increasing the pitch of the irradiation. 
With increasing radius, 200 keV achieve a lower dose in the regarded region than 150 keV photons, which is 
assumed to be advantageous. Where no data points are plotted (occurring in subplot (d) in the bone region), the 
valley dose entirely exceeds the tomotherapy dose at this radius.
The volume fraction that receives a lower dose than the reference tomotherapy dose is plotted in subplots 
(g)–(i). A large value is desired here, since it corresponds to a larger region where tissue damage is probably less 
severe than with tomotherapy. Here again, the 6-port interlaced geometry performs best in proximity of the 
target, but then rapidly declines. Increasing the spiralMRT pitch increases the volume fraction staying below the 
tomotherapy dose to some extend. Here, 150 keV photons produce slightly larger valley regions than 200 keV 
photons, except for the bone region.
The last row of subplots (j)–(l) scores the width of the region where the peak dose is above the tomotherapy 
dose. The entrance peaks (open symbols) for 150 keV photons are considerably smaller than for 200 keV. The 
energy-dependence for the exit beams (solid symbols) is less pronounced than for the entrance beams.
Furthermore, the beam pitch has a high impact on the peak width. While the minimum peak width is around 
80 µm for 200 keV photons with 300 µm pitch, the minimum width at 600 µm pitch is in the order of 110 µm.
Figure 5. Dose profiles for different spatial fractionation schemes corresponding to set 1 in table 1 with 300 µm pitch and 20× 20 
mm2 total field size. The first three columns show spiralMRT and the fourth column a 6-port interlaced geometry. At r  =  80 mm the 
high absorption in the bone increases the dose. For comparison, the dose from the corresponding 2 MeV tomotherapy irradiation 
has been plotted as grey curve.
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Figure 6. Dose profiles for spiralMRT with an increased pitch of 450 µm and 600 µm corresponding to set 2 in table 1. Tomotherapy 
shown in grey for comparison.
Figure 7. Radial dose profiles for 300 µm pitch spiralMRT at different energies and 2 MeV tomotherapy according to the definition 
in figure 4. The microbeam is entering from the left in this figure. Thus, the peak dose to the left of the target (r  =  0) represents the 
entrance peak and to the right it represents the exit peak.
Phys. Med. Biol. 64 (2019) 065005 (13pp)
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5. Estimation of the dose rates and exposure times
The rotation of the patient or the rotation of the source around the patient during irradiation has implications 
on the dose rates needed for a successful treatment. The faster the angular velocity is, the shorter the microbeam 
exposure time at the beam entrance becomes, which limits the effects of motion-induced blurring during 
irradiation. However, the dose rate, which is inversely proportional to the exposure time, needs to be increased 
accordingly.
The upper limit for patient rotation has been estimated to be 120◦ s−1 during synchrotron computed tomog-
raphy imaging with humans (Renier 2016). An angular velocity of 90◦ s−1 is used there on a regular basis (Renier 
2016).
The achievable target dose as a function of dose rate at reference conditions and the employed scan param-
eters were determined by comparison with the dose scored in a simulation of a 20 mm× 20 mm non-divergent 
radiation field impinging on a cubic 163 cm3 water phantom in 20 mm depth from the phantom surface.
Using 200 keV photons and a hypothetical dose rate of 100 Gy s−1 at reference conditions and a linear comp-
onent of the helical motion of 0.1 mm s−1, the target dose would be 18.8 Gy and the revolution period 3 s, 4.5 s 
and 6 s for a pitch of 300 µm, 450 µm and 600 µm, respectively. 100 Gy s−1 is by a factor of 10–100 lower than the 
dose rates currently used in synchrotron-based MRT.
Figure 8. Dose profiles for spiralMRT for different fields sizes and a constant pitch of 600 µm corresponding to set 3 in table 1. In 
the third column the bottom four datasets have been scaled with a factor of five for better visibility. Tomotherapy shown in grey for 
comparison.
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The required exposure time for this configuration is plotted as a function of the radius from the rotation axis 
in figure 10. In outer regions, where the tangential velocity is high, the exposure time is limited by the rotational 
movement and follows approximately an r−1 relationship. At smaller radius the exposure time is determined by 
the linear motion and independent of the radius.
In general, the exposure time is lowered by reducing the width of the field and by reducing the microbeam 
pitch at constant linear velocity.
6. Discussion
SpiralMRT presents an innovative approach in MRT with moderate entrance doses and could thereby reduce 
risks associated with peak doses in the hectogray region. At the same time it offers an opportunity to achieve 
a homogeneous high dose coverage of the target region, which is advantageous when comparing treatment 
outcome to conventional RT or when predicting tumour response. As mentioned in section 5, the demand for a 
high dose rate radiation source is much lower than in synchrotron based MRT with static beam directions.
In consistence with previous publications (Spiga et al 2007, Shinohara et al 2014) on MRT, 100 keV photons, 
which are closest to the spectrum currently used in MRT at the ESRF (Crosbie et al 2015) and the Australian 
Synchrotron (Livingstone et al 2016), are below the optimum energy for spiralMRT. 150 keV and 200 keV offer 
a better penetration due to reduced x-ray absorption. As a result, the valley doses are substantially lower than for 
100 keV. Photon energies above 200 keV are assumed to have too large secondary particle ranges, which will lead 
to a larger microbeam penumbra and increased valley dose.
Figure 9. Compilation of different spatial fractionation properties of spiralMRT compared to the corresponding tomotherapy dose 
from sets 1 and 2 in dependence of the radius from the rotation axis. The grey shaded region represents the bone layer. All graphs 
share a common horizontal axis which is only labelled in the bottom line and represents the radius from the central rotation axis of 
the irradiation. The three columns represent datasets of equal pitch for the interlaced MRT and spiralMRT simulations (marked 
on top of each column). For each configuration, the tomotherapy dose for the same 20× 20 mm2 radiation field is plotted for 
comparison in the top row. The errorbars mark confidence intervals of one standard deviation. (a)–(c) The mean dose in the valley 
region that has a dose lower than the corresponding tomotherapy dose (marked as 2 MeV and plotted for comparison). (d)–(f) Same 
as the row above, but normalised by the tomotherapy dose at the same radius. (g)–(i) The volume fraction receiving a spiralMRT 
dose lower than the corresponding tomotherapy dose. (j)–(l) The width of the microbeams measured as the width of the regions 
having a dose higher than the corresponding tomotherapy dose. In these plots, open symbols represent the entrance beam, solid 
symbols the exit beam.
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The valley dose can be successfully lowered and the valley region widened by increasing the beam pitch for 
spiralMRT, as seen in figure 9. However, the linear component of the motion introduces an increased microbeam 
spread resulting in wider beams. The beam pitch is likely to be limited by this effect in order to keep microbeams 
spatially confined.
The normal tissue sparing of microfractionated radiation fields offers new opportunities to deliver safely 
high amounts of dose in one single temporal fraction, which is associated with an increased risk of developing 
negative normal tissue side effects in conventional brain metastases treatment (Minniti et al 2016). With the nor-
mal tissue sparing capability of spiralMRT, the tolerance of single fraction RT could be increased, it would reduce 
the treatment time for palliative treatment by moving from multiple fractions to one fraction and it may even 
offer new opportunities for curative approaches.
7. Conclusion
The spatial fractionation of the entrance beams in spiralMRT can help sparing normal tissue when compared 
to tomotherapy. It has been shown that valley doses are 40% lower than corresponding tomotherapy doses (see 
figures 9 (e) and (f)), while a homogeneous dose can be maintained in the target region.
The beam width is affected by the linear component of the helical motion, but nominally 50 µm wide beams 
do not exceed 100 µm effective beam width, when a pitch of 450 µm or lower is applied. Beams exceeding this 
threshold are associated with a rapidly decreasing normal tissue recovery (Serduc et al 2014).
Necessary dose rates will be substantially higher than in conventional RT, but by two orders of magni-
tude lower than currently employed dose rates at synchrotron sources used for MRT (100 Gy s−1 instead of 
10 kGy s−1). The associated risk of over-dosage when handling such high dose rates is reduced accordingly.
The increased photon absorption in the bone region is a common disadvantage of spiralMRT and interlaced 
MRT, when confronted with conventional megavoltage RT, which leads to an increased dose deposition and 
might locally impair positive effects.
This physical evaluation of the potential of spiralMRT overall comes to a positive conclusion, the next step 
should be biological experiments on the anticipated benefits to healthy tissue.
8. Outlook
This publication introduces the basic idea of spiralMRT and highlights certain parameters. Many more 
optimisations could be done, improving the quality of a spiralMRT treatment, such as introducing intensity 
modulation to spare organs at risk in the beam path and to ensure a homogeneous irradiation of non-centrally 
located targets. Conformal irradiation would reduce the valley dose that is correlated with the total beam cross 
section (Martínez-Rovira et al 2012). The dependence of the setup on angular misalignment of the primary 
microbeam and the rotation axis, as well as the technical feasibility with currently available equipment are further 
points to be investigated.
Compact radiation sources reaching sufficient dose rates are probably available in the mid-term future with 
a suitable x-ray energy spectrum. Inverse Compton scattering sources (Jacquet 2014) are currently under devel-
Figure 10. The exposure time during which the primary microbeam irradiates a certain point in space in dependence of its radius 
from the rotation axis. Data is plotted for 300 µm, 450 µm and 600 µm pitch and for 2 mm, 10 mm and 20 mm field width. The linear 
component of the spiral motion is 0.1 mm s−1 for all cases, which keeps the target dose constant. To increase the beam pitch, the 
angular velocity must be reduced, resulting in higher exposure times for larger pitches.
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opment at different sites and are expected to produce 1013 photons per second (Jacquet and Suortti 2015). Dis-
tributed over a 20 mm× 20 mm reference field, this flux corresponds to an approximate dose rate of 1 Gy s−1 in 
20 mm depth in water for 100 keV photons. Taking into account that the actually used field in this case is only 50 µm 
high, an appropriate focusing of the photon flux to the aperture will easily lead to an increase of the dose rate by 
a factor of 10 or more. Thus, the technical demands on the radiation flux for spiralMRT may be met in the future 
by inverse Compton scattering sources.
Another yet theoretical concept are line-focus x-ray tubes (Bartzsch and Oelfke 2017) which may deliver dose 
rates in the order of 100 Gy s−1 and radiation fields with centimetre-sized diameter.
The beam divergence is an important factor when it comes to novel radiation sources. It may broaden the 
spiralMRT exit beam, while the entrance beam would profit from a better focusing. As soon as the specifications 
of candidate sources are known, an investigation of the effect should take place. However, the ThomX inverse 
Compton source is expected to deliver radiation within a 1.5 mrad cone (half opening) (Jacquet and Suortti 
2015), i.e. 30 mm beam diameter at 10 m distance from the source.
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